NASDAQ · VACQ
Vector Acquisition Corporation
$11.57+$0.50 (+4.52%)
Vector Acquisition Corporation’s quoted price sits in the upper half of its reported 52-week range, 2.61% below the high.
Loading market information…
NYSE · IBER · USD
Stock price, earnings
Quote as of Mar 1, 2023, 08:58 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Ibere Pharmaceuticals’s quoted price sits in the lower half of its reported 52-week range, 5.3% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Ibere Pharmaceuticals’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Ibere Pharmaceuticals currently lacks significant operational activities, with its core mission focused on executing a business combination. This could involve a merger, an acquisition of assets or shares, or a corporate restructuring with one or more other entities. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$11.57+$0.50 (+4.52%)
Vector Acquisition Corporation’s quoted price sits in the upper half of its reported 52-week range, 2.61% below the high.
$11.14-$0.01 (-0.09%)
Slam Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.89% below the high.
$11.47+$0.48 (+4.37%)
Tristar Acquisition I Corp.’s quoted price sits in the upper half of its reported 52-week range, 4.5% below the high.
$6.15-$0.26 (-4.06%)
Bridgetown Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 41.04% below the high.
$11.45-$0.01 (-0.04%)
AP Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 7.77% below the high.
$9.95-$0.05 (-0.5%)
Parabellum Acquisition Corp.: Financial Services · Shell Companies.
$10.49-$0.02 (-0.19%)
Fusion Acquisition Corp. II’s quoted price sits in the upper half of its reported 52-week range, 2.42% below the high.
$10.87-$0.83 (-7.09%)
Learn CW Investment Corporation’s quoted price sits in the upper half of its reported 52-week range, 15.8% below the high.
